Kathmere Capital Management, LLC Neuro Metrix, Inc. Transaction History

Kathmere Capital Management, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2021 May 07, 2021	SELL	$3.01 - $5.35 $6 - $10	-2 Closed	0 $0
Q3 2020 Nov 20, 2020	BUY	$1.48 - $2.26 $2 - $4	2 New	2 $0

320

Ticker NURO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 7,757,230
Market Cap $28.3M
Description
NeuroMetrix, Inc., a healthcare company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico. Its primary marketed products include DPNCheck, a nerve conduction test that is used to e...

Get notified when there are updates to the investment portfolio of Kathmere Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Kathmere Capital Management, LLC with notifications on news.